09:43 AM EST - Theralase Technologies Inc. : Has completed manufacture of its lead Photo Dynamic Compound, TLD-1433 in compliance with Good Manufacturing Practice standards. This milestone is critical for a Clinical Trial Application submission to Health Canada. Theralase Technologies Inc.
shares V.TLT are trading unchanged at $0.28.
